E-viri
PDF
Recenzirano
Odprti dostop
-
Passiglia, Francesco; Bronte, Giuseppe; Bazan, Viviana; Galvano, Antonio; Vincenzi, Bruno; Russo, Antonio
Critical reviews in oncology/hematology, 03/2016, Letnik: 99Journal Article
Highlights • KRAS and BRAF mutations as predictors of recurrence-free survival (RFS) or overall survival (OS) in colorectal cancer patients who underwent surgical treatment of CRC liver metastases (CLM). • Meta-analysis to estimate the prognostic value of both KRAS and BRAF mutations in colorectal cancer patients who underwent surgical treatment of CRC liver metastases (CLM). • KRAS and BRAF mutations are prognostic biomarkers, associated with worse survival outcomes in patients undergoing hepatic resection of CLM.
